Search results
Results from the WOW.Com Content Network
Stocks of coronavirus vaccine could run out at the end of January unless new ones such as the Oxford jab are approved, a former minister has warned. Former health secretary Jeremy Hunt told the ...
Kennedy has long railed against vaccines, once calling those that protect against Covid-19 a "crime against humanity." He has treaded more carefully in recent weeks, though, and has said he wouldn ...
But Novavax's COVID-19 vaccine -- whose commercialization rights Sanofi will soon own in most countries -- continues to be a distant third in the U.S. market. Novavax's combined coronavirus/flu ...
Trump said during a rally in late October that he would let Kennedy “go wild” on healthcare in the country, and vaccine stocks like Moderna and Novavax have been heading lower since. Thursday ...
Like a fad that arrived and left, Covid-19 vaccine stocks are out of favor now. Novavax (NASDAQ:NVAX) is facing tremendous selling pressure compared to its peers. Unlike its competitors that ...
An hour before the market closed Thursday, as news reports of Trump’s choice began trickling out, Covid-19 vaccine maker Moderna dipped as much as 6%, and Pfizer fell almost 2%.
Novavax (NASDAQ:NVAX) saw its shares rise yesterday amid positive social media momentum, but they have been just as quick to fall today due to bad news. Negative delivery statistics have pushed ...
Pfizer (PFE) and Moderna (MRNA) are the only two companies that have submitted data and are seeking approval for a booster or "third" dose of their COVID-19 vaccines.